Sign in
Home
Biotech Insights
Biotech News
CEO Interviews
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
Sign in / Join
About Us
Privacy Policy
Disclaimer
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Home
Biotech Insights
Biotech News
CEO Interviews
CEO Interviews
BiotechStocktrader Interview with Nader Pourhassan, CEO of Cytodyn, Inc.
CEO Interviews
BiotechStocktrader Interview with Dr. Carl Schwartz, CEO of Precision Therapeutics, (AIPT).
CEO Interviews
BriaCell Therapeutics (BCTXF) Presents Positive Efficacy Data with Lead Cancer Drug Candidate
CEO Interviews
Hemispherx Biopharma (HEB) Showing Strong Progress in Clinical Trials
CEO Interviews
Innovus Pharmaceuticals Continues Strong Revenue Growth & New Product Rollouts
BioTechStockTrader
About Biotech Stocktrader
Alernative Pharma
Biotech Insights
Biotech News
CEO Interviews
COVID-19
By review score
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Biotech News
Home
Biotech News
No posts to display
- Advertisement -
APPLE
MEI Pharma Halts Phase 3 Study of Blood Cancer Drug Candidate
Andrew M.
-
July 6, 2020
0
Biotech News
Small cap biotechnology company MEI Pharma (NASDAQ:MEIP) in conjunction with Swiss pharmaceutical company Helsinn Group announced the discontinuation a collaborative Phase 3 study of...
RECENT POSTS
Cardiol Therapeutics Submits Application for Uplisting to the Nasdaq and Raises Proceeds of Over...
Paul Archie
-
March 2, 2021
Big Pharma Dives Into CBD: Who Could Be Next?
Paul Archie
-
February 22, 2021
Clinical Trials Focus on COVID-19 and Acute Myocarditis
Paul Archie
-
January 19, 2021
Cardiol Therapeutics Announces Completion of Phase I Clinical Study of CardiolRx™
Paul Archie
-
December 22, 2020
